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Abstract
Attine ants are dependent on a cultivated fungus for food and use antibiotics produced by symbiotic Actinobacteria as
weedkillers in their fungus gardens. Actinobacterial species belonging to the genera Pseudonocardia, Streptomyces and
Amycolatopsis have been isolated from attine ant nests and shown to confer protection against a range of microfungal
weeds. In previous work on the higher attine Acromyrmex octospinosus we isolated a Streptomyces strain that produces
candicidin, consistent with another report that attine ants use Streptomyces-produced candicidin in their fungiculture. Here
we report the genome analysis of this Streptomyces strain and identify multiple antibiotic biosynthetic pathways. We
demonstrate, using gene disruptions and mass spectrometry, that this single strain has the capacity to make candicidin and
multiple antimycin compounds. Although antimycins have been known for .60 years we report the sequence of the
biosynthetic gene cluster for the first time. Crucially, disrupting the candicidin and antimycin gene clusters in the same
strain had no effect on bioactivity against a co-evolved nest pathogen called Escovopsis that has been identified in ,30% of
attine ant nests. Since the Streptomyces strain has strong bioactivity against Escovopsis we conclude that it must make
additional antifungal(s) to inhibit Escovopsis. However, candicidin and antimycins likely offer protection against other
microfungal weeds that infect the attine fungal gardens. Thus, we propose that the selection of this biosynthetically prolific
strain from the natural environment provides A. octospinosus with broad spectrum activity against Escovopsis and other
microfungal weeds.
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Introduction
Insect fungiculture has been best studied in the attine ants
(subfamily Myrmicinae, tribe Attini) whose common ancestor is
estimated to have evolved agriculture around 50 million years
ago [1]. Attine ants are so dependent on the cultivation of fungus
that when a daughter queen leaves to found a new nest she
carries a piece of the cultivar fungus in her mouth in order to
establish a culture of that fungus in her new nest [1]. Intriguingly,
attine ants have also evolved a mutualism with Actinobacteria
that produce antibiotics that the ants use as weedkillers to keep
their fungal gardens free of other microbes [2,3,4]. The
relationship between Actinobacteria, fungal cultivar and attine
ant has been intensely studied in the branch of higher attines
known as the leaf-cutting ants (genera Atta and Acromyrmex) which
harvest fresh vegetation to feed to their highly specialised fungal
cultivar, Leucoagaricus gongylophorus [1]. The fungus has evolved
lipid and carbohydrate rich hyphae known as gongylidia which
the ants harvest and use as food [5]. Pathogens of the fungal
garden, most notably fungi of the genus Escovopsis, if left
unchecked, can destroy a fungal garden and lead to the collapse
of the colony within weeks [6,7].
Two overlapping but conflicting theories have been put
forward to explain the evolution of mutualism between attine
ants and Actinobacteria. The first suggests co-evolution of attine
ants and Actinobacteria belonging to the genus Pseudonocardia.
This theory suggests that the fungus garden pathogen Escovopsis
has also co-evolved and that Pseudonocardia and Escovopsis are
engaged in an evolutionary arms race in which the bacteria
evolve compounds that specifically target Escovopsis but do not
inhibit the growth of the fungal cultivar [5]. The second model
suggests that attine ants select antifungal-producing Actinobac-
teria from the environment and is consistent with the identifica-
tion of additional Actinobacterial genera on leaf-cutting ants,
including Streptomyces and Amycolatopsis species [3,4,8,9]. However,
these theories are not mutually exclusive and evidence suggests
attine ants co-evolve with Pseudonocardia bacteria and still select
other antifungal producing bacteria from the soil, perhaps to
prevent evolution of resistance in the fungal pathogens [9,10].
Indeed, there is good evidence, both direct and indirect, that leaf-
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cutting ants use multiple antifungals produced by multiple
Actinobacteria during the cultivation of their fungal gardens
suggesting that both models do apply, at least in the higher attine
genus Acromyrmex [3,11]. Recent work demonstrated that
Acromyrmex octospinosus are associated with a Pseudonocardia strain
that may have co-evolved and a Streptomyces strain that was most
likely acquired from the environment relatively recently [9].
One intriguing question that still needs to be addressed in the
environmental recruitment model concerns how the ants select
beneficial bacteria. Actinobacteria are well known producers of
useful secondary metabolites, including around 60% of all known
antibiotics [12] and it seems likely that this production capability is
key to their success as mutualists. Clearly the production of
antifungals makes them useful to the ants and we hypothesise that
production of multiple antifungals with different targets by single
Actinobacterial species would make them more attractive to the
ants as mutualists. In this work we carry out a more in depth
analysis of the antifungals made by one of the strains associated
with the leaf-cutting ant A. octospinosus, a species of Streptomyces
which has been proposed to support fungus growing ants through
production of the polyene antifungal candicidin [4,9]. We report
the genome sequence and analysis of this strain indicating its
capacity to make numerous antibiotics, including at least three
antifungal compounds. Curiously, this strain makes both of the
antifungals that have been reported in the Streptomyces attine ant
mutualists but neither the candicidin or antimycins are obligatory
for the inhibition of the co-evolved nest pathogen E. weberi. We
propose that additional and as yet unknown antifungal(s) made by
this strain specifically target Escovopsis and that candicidin and
antimycins offer protection against other microfungal weeds. We
propose that the ability of this single species to make multiple
antifungal compounds makes it an attractive acquisition for the
ants and their fungiculture.
Results
Genome sequencing and analysis
To determine the antibiotic biosynthetic capability of Streptomy-
ces S4 a combination of shotgun, 3 kbp and 8 kbp paired end
libraries were constructed and 454 pyrosequenced to generate
.335 Mbp of sequence that was assembled into 12 scaffolds
containing 211 large contigs. The genome consists of one
,7.5 Mbp linear chromosome, which is within the size range
reported for genomes of other sequenced streptomycetes, as well as
one linear plasmid (,180 kbp) and one circular plasmid (,2 kbp)
[13]. The Streptomyces S4 genome was annotated by a combination
of manual and automated methods and multiple biosynthetic gene
clusters predicted to produce secondary metabolites were identi-
fied. Table 1 summarizes characteristics of predicted natural
product biosynthetic gene clusters in Streptomyces S4. As expected
based on our previous work, the Streptomyces S4 genome contained
a candicidin biosynthetic gene cluster that shares 98% nucleotide
sequence identity with the candicidin biosynthetic gene cluster
from Streptomyces sp. FR-008 [14]. Other biosynthetic gene clusters
of note are a non-ribosomal peptide synthetase (NRPS) biosyn-
thetic gene cluster that is predicted to direct the biosynthesis of an
antibacterial similar to mannopeptimycin, as well as a NRPS
biosynthetic gene cluster whose predicted product is a gramicidin-
like antibacterial. We note these antibacterials could be useful in
eliminating competition during colonisation of the ant cuticle.
Streptomyces S4 also contains a type II polyketide synthase (PKS)
biosynthetic gene cluster that shares 100% nucleotide identity to
that of the fredericamycin biosynthetic gene cluster characterized
in S. griseus [15]. Fredericamycin is mostly known for its antitumor
properties [16]. Additionally, there are six functionally unassigned
biosynthetic gene clusters (three NRPS and three hybrid NRPS/
PKS) that are not similar to gene clusters with known products. It
Table 1. Putative secondary metabolites encoded by Streptomyces S4.
Predicted biosynthetic system Genome coordinates
Predicted metabolite or close
relative Biological properties
Hopene / squalene synthase scaffold08: 588141–598581 Hopanoids Membrane stabilizers
NRPS-independent siderophore synthetase scaffold05: 959198–972403 Desferrioxamine Siderophore
NRPS-independent siderophore synthetase scaffold08: 1448607–1457963 Unknown Unknown
Ectoine synthase scaffold05: 68880–72152 Ectoine Osmolyte
Phytoene / polyprenyl synthase scaffold06: 410147–419826 Carotenoids Pigment
Terpene synthase scaffold08: 1719586–1721871 Geosmin Unknown
Type III PKS scaffold06: 295706–300701 1,3,6,8-tetrahydroxynaphthalene Pigment
Type I PKS scaffold06: 115150–253654 Candicidin Antifungal
Type I PKS / Type III PKS scaffold05:1001127–1064995 Kendomycin Anticancer
Type II PKS scaffold08: 3878554–3911349 Fredericamycin Anticancer
Hybrid NRPS / PKS scaffold06: 81953–106578 Unknown Unknown
Hybrid NRPS / PKS scaffold06: 7264–45109 Unknown Unknown
Hybrid NRPS / PKS scaffold08: 503983–520001 Unknown Unknown
NRPS scaffold08: 4240081–4309220 Gramicidin Antibacterial
NRPS scaffold08: 3002155–3042863 Mannopeptimycin Antibacterial
NRPS scaffold06: 65083–81878 Unknown Unknown
NRPS scaffold08: 276268–301035 Unknown Unknown
NRPS scaffold08: 3930113–3950474 Unknown Unknown
NRPS, non-ribosomal peptide synthetase, PKS, polyketide synthase.
doi:10.1371/journal.pone.0022028.t001
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is likely that at least some these clusters encode secondary
metabolites with antibacterial or antifungal activity.
Mutagenesis of the candicidin biosynthetic gene cluster
does not abolish antifungal activity
Evidence that candicidin is not the sole antifungal generated by
Streptomyces S4 is demonstrated by the retained antifungal activity
of a mutant strain deficient in the biosynthesis of this compound.
The candicidin biosynthetic gene cluster was disrupted by deletion
of the polyketide synthase gene, fscC, which encodes the candicidin
biosynthetic modules 6–10 [14]. LC-MS analysis of butanol-
extracted culture supernatants from the wild-type strain revealed a
molecular ion (m/z 1109.6) consistent with that of candicidin D
and showed characteristic polyene absorption bands in its UV
spectrum, with absorbance maxima at 360, 380, 403 nm (Fig. 1).
As predicted, the molecular ion m/z 1109.6 was not detected in
the DfscC mutant, indicating that candicidin production is
abolished in this strain (Fig. 1). Bioassays of the isogenic wild-
type and DfscC strains against C. albicans and the nest pathogen
Escovopsis weberi demonstrated that loss of candicidin has no effect
on the antifungal bioactivity of Streptomyces S4 (Fig. 2). This result
suggests that Streptomyces S4 makes at least one additional
antifungal compound that has not been identified previously,
most likely encoded by one of the other biosynthetic gene clusters
identified in this work.
Identification of the antimycin biosynthetic gene cluster
While this work was in progress another group reported that
antimycins are produced by a number of the other Streptomyces
strains associated with attine ant nests [17]. Antimycins inhibit the
respiratory chain and are known to have antifungal activity. We
investigated whether Streptomyces S4 is making antimycin com-
pounds in addition to candicidin and hypothesised that antimycins
could potentially account for the retained bioactivity against
Escovopsis observed for the Streptomyces S4 fscC mutant. LC-MS
analysis of culture supernatants of the wild-type strain identified
eight compounds with m/z that match those reported for
antimycins A1–A4 (Fig. 3). To determine if any of the eight
compounds could be antimycins, we co-injected commercially
available antimycin standards A1–A4 with our wild-type extract,
which revealed that four of the eight compounds possess the same
retention time as the antimycin A1–A4 standards (Fig. 3). Four of
the eight S4 compounds were identical to the commercially
available antimycin standards A1–A4 both in terms of UV
absorbance profile and LC retention time. Whilst the remaining
four S4 compounds possess the same UV absorbance character-
istics as the antimycin standards (Fig. S1), and the same m/z parent
ions as those of the standards, they exhibit different retention times
(Fig. 3); further experiments are being carried out to identify and
characterize these four previously unreported compounds.
To our knowledge the gene cluster that encodes the antimycin
biosynthetic pathway has not been identified, despite these
compounds first being isolated over 60 years ago [18]. The
structure of antimycin suggests that it may be synthesized, at least
in part, by an NRPS, and that threonine may be utilized as a
substrate (Fig. 3). The Basic Local Alignment Search Tool [19]
revealed a region of the Streptomyces S4 genome with 57% amino
acid sequence identity to the threonine adenylation domain from
the daptomycin biosynthetic protein, DptA [20]. This region of
homology enabled us to identify a hybrid NRPS/PKS biosyn-
thetic gene cluster that displays significant amino acid identity to
a hybrid NRPS/PKS biosynthetic gene cluster present in both
S. albus and S. ambofaciens and potentially encodes for the
biosynthesis of antimycins (Fig. 4). Table 2 displays the proposed
functions of proteins present in the hybrid NRPS/PKS cluster. In
order to determine if this biosynthetic gene cluster can direct the
production of antimycin, we disrupted the hybrid NRPS/PKS
gene, antC and assessed antifungal activity against C. albicans in a
plate bioassay. The DantC mutant displayed dramatically reduced
antifungal activity against C. albicans compared to that of the wild-
type strain (Fig. 2). This strongly suggested that the product of
this cluster was an antifungal compound and is consistent with
the hypothesis that this cluster could potentially mediate the
biosynthesis of antimycins, compounds known to possess strong
antifungal activity against C. albicans (Fig. 2). Confirmation that
the hybrid NRPS/PKS encoded by Streptomyces S4 directs the
biosynthesis of antimycins was obtained by comparing the LC-
MS profiles of the wild-type, DfscC and DantC mutant strains.
Extracted ion chromatograms revealed that the DantC mutant
does not produce the eight antimycins and that the DfscC mutant
retained the ability to produce these antimycin compounds
(Fig. 3).
Figure 1. Deletion of the candicidin biosynthetic gene, fscC
abolishes production of candicidin. LC-MS was used to analyze
supernatant from Streptomyces S4 wild-type and S4 DfscC. The
extracted ion chromatogram for candicidin (m/z 1109.6) is shown and
confirmed that only S4 wild-type and not the DfscC mutant produced
candicidin. The UV visible spectra for the peak at RT 5.15 min displays
absorption characteristics consistent with polyene compounds is also
shown (bottom).
doi:10.1371/journal.pone.0022028.g001
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A Streptomyces S4 mutant which cannot make candicidin
or antimycins still has antifungal activity against E. weberi
Our bioassays against E. weberi with the DfscC and DantC mutant
strains of Streptomyces S4 did not show a reduction in bioactivity
against this nest parasite indicating that key antifungal com-
pound(s) affording protection against the natural fungal pathogen
still remain to be identified (Fig. 2). To determine whether
additional antifungals are made by Streptomyces S4 we generated a
new mutant in which the fscC and antC genes were disrupted in the
same strain and assessed the bioactivity of this strain against C.
albicans and E. weberi. As we predicted, the antifungal activity of the
DfscC DantC double mutant against E. weberi was comparable to
that of the wild-type strain, confirming that additional antifungal
compound(s) made by Streptomyces S4 account for the majority of
the antifungal activity observed against E. weberi in vitro. The
additional antifungal(s) may be encoded by one of the five
functionally unassigned biosynthetic gene clusters identified in our
genome analysis (Table 1) or by a gene cluster not identified in our
analysis.
Discussion
Although the attine ant-fungal mutualism has been studied for
more than a century, the antibiotic-producing Actinobacterial
mutualists were only discovered ,15 years ago and it is only very
recently that scientists have started to address the nature of the
antibiotics being produced by these bacteria [2,4,9,17]. It has been
hypothesised, although not proven, that these antibiotics are used
by the ants to kill off contaminated parts of the garden and / or to
suppress the growth of fungal pathogens including co-evolved
pathogens in the genus Escovopsis and many other microfungal
weeds [6,7]. Recent studies have shown that strains belonging to
two key genera are typically associated with attine ants, species of
Pseudonocardia, which have been suggested to have co-evolved with
the ants and to be transmitted vertically by the queens, and species
of Streptomyces which have been suggested to be more recently
acquired from the environment [3,4,8,9]. Two antifungals have
been identified from proposed mutualist species in each genus and
both inhibit the nest pathogen Escovopsis in vitro. Pseudonocardia
associated with the lower attine A. dentigerum makes dentigerumycin
and Pseudonocardia associated with the higher attine A. octospinosus
makes nystatin P1 [2,9]. Streptomyces mutualists associated with
higher attines of the genus Acromyrmex are known to produce the
well-known antifungals candicidin and antimycins and it has been
suggested that these compounds account for the bioactivity of this
Streptomyces strain against Escovopsis [4,9,17]. To date almost all of
this work has been carried out through isolation and mass
spectrometry analysis of the antifungal compounds, although we
used genome scanning of a Pseudonocardia mutualist to identify a
nystatin-like biosynthetic gene cluster and its product which we
named nystatin P1 [9].
In this work we have undertaken the first in-depth genome
sequence analysis of a proposed attine ant mutualist, in this case a
candicidin-producing Streptomyces strain isolated from A. octospinosus
garden worker ants collected in Trinidad [9]. Genome sequencing
and analysis identified 17 gene clusters that are predicted to
encode for known or unknown secondary metabolites, including
the known gene cluster for candicidin biosynthesis. Following the
discovery of antimycin production by Streptomyces strains isolated
from attine ants in a separate study [17] we identified a gene
cluster encoding a pathway that is consistent with antimycin
biosynthesis. Surprisingly, despite antimycins first being isolated
and characterised .60 years ago the antimycin biosynthetic
pathway was not known. We identified eight compounds which we
assigned as antimycins and then identified and disrupted the
hybrid NRPS/PKS gene cluster which we predicted to encode
antimycin biosynthesis. The production of the eight antimycin
compounds was abolished in the mutant strain providing strong
evidence that this gene cluster does indeed encode the antimycin
biosynthetic pathway.
In bioassays of the wild-type Streptomyces S4 strain alongside
strains which cannot make candicidin, antimycins or either of
these antifungal compounds we found that whilst antimycin- and
candicidin-deficient strains had reduced activity against the
Figure 2. Antifungal bioactivity of the non-antifungal-producing strain Streptomyces lividans, Streptomyces S4 wild-type and mutant
strains. Bioassays with Streptomyces lividans, S4 wild-type, S4 DfscC, S4 DantC and S4 DfscC DantC against Escovopsis weberi (top panel) and
C. albicans (bottom panel) demonstrate that deletion of fscC does not abolish antifungal activity and that deletion of antC only reduces antifungal
activity against C. albicans and not E. weberi. The S4 DfscC DantC double mutant does not display reduced antifungal activity against E. weberi
suggesting the presence of an additional antifungal compound that is responsible for the phenotype observed during in vitro bioassays.
doi:10.1371/journal.pone.0022028.g002
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human pathogen C. albicans their activity against the nest pathogen
E. weberi was unaltered. This is curious as the Streptomyces S4 strain
and E. weberi are thought to have co-evolved in this mutualism
[21]. This suggests that despite previous research demonstrating
that purified candicidin and antimycin preparations inhibit the
growth of Escovopsis in vitro neither compound is responsible for
the activity observed in bioassays where Streptomyces S4 is
challenged with E. weberi. We conclude that these compounds
potentially inhibit the growth of other microfungal weeds found in
the ant-fungus gardens while additional and currently unknown
antifungal(s) produced by Streptomyces S4 have stronger activity
against Escovopsis. We also propose that the combination of
antifungals produced by this single Streptomyces strain coupled with
the antifungal(s) produced by a Pseudonocardia strain isolated from
the same nest provides a broad spectrum of antifungal activity that
is used by the ants to farm their fungus. Furthermore, the
antibacterials made by Streptomyces S4 potentially help it to
outcompete other bacteria for the ant host.
Our data suggest that the Streptomyces strains isolated by other
researchers from attine ants are likely to make additional
antifungals since they appear to be closely related to Streptomyces
S4. It will be important to re-examine the biosynthetic capability
of these strains in order to fully understand the chemical basis of
their interactions with attine ants and their fungal cultivar. This
reflects a common problem in the field of natural product
antibiotic discovery, in which the reisolation of known compounds
hampers the discovery of new antibiotics. The approach we have
outlined here is time consuming and technically challenging, but it
is perhaps the only way to determine the entire biosynthetic
capability of an antibiotic-producing strain particularly if some of
the antibiotics being made, and their biosynthetic gene clusters,
are new to science. Future work will be aimed at determining the
products of the five unassigned biosynthetic gene clusters in
Streptomyces S4 and identifying the additional antifungal com-
pound(s) made by this strain. This is likely to involve significant
challenges if, as we predict, these are novel secondary metabolites.
In conclusion, although good progress has been made recently
we are still a long way from understanding the chemical basis of
the symbioses between antibiotic-producing Actinobacteria and
their attine ant hosts. We hope that our study will stimulate further
research in this area and the identification of additional antifungal
and antibacterial compounds in this system.
Materials and Methods
Growth media and strains
Streptomyces strains were routinely grown on soya flour mannitol
(SFM) agar plates or in liquid TSB/YEME while E. coli strains
were grown on Lysogeny both- Lennox (LB) [22]. Media was
supplemented with antibiotics as required at the following
concentrations: carbenicillin (100 mg/ml), hygromycin B (50 mg/
ml), nalidixic acid (25 mg/ml), apramycin (50 mg/ml). S4 was
isolated and identified by 16S rDNA sequencing in a previous
study (GenBank accession HM179229). Antifungal bioassays with
C. albicans and E. weberi were carried out as described previously
[9]. Strains and plasmids are described in Table 3.
Construction of Streptomyces S4 mutant strains
In order to create the DfscC mutant, two 3 kb knockout arms
were PCR amplified using GoTaq Polymersae (Promega) with
oligonucleotide primers RFS78 and RFS79 (upstream arm) and
RFS80 and RFS81 (downstream arm), respectively. Oligonucle-
otide primers (Integrated DNA Technologies) were engineered at
their 59 end to contain restriction sites for cloning (Table S1). The
Figure 3. LC/MS analysis of Streptomyces S4 wild-type and
mutant strains compared to antimycin standards. The extracted
ion chromatograms for antimcyins A1–A4 are shown. Eight compounds
consistent with the mass of antimycin A1–A4 were produced by S4
wild-type and S4 DfscC, but were not produced by the DantC mutant.
Co-injection of antimycin A1–A4 with the S4 wild-type extract
demonstrated that antimycin A1–A4 have the same retention time as
four of the eight compounds produced by S4 wild-type. The UV visible
spectra and ESI positive mode mass spectra for antimycin A1–A4 and
the eight antimycin compounds produced by S4 wild-type are shown in
Fig. S1 and Fig. S2, respectively. Antimycin A1: R1 = CH(CH3)CH2CH3,
R2 = (CH2)5CH3. Antimycin A2: R1 = CH(CH3)2, R2 = (CH2)5CH3. Antimycin
A3: R1 = CH(CH3)CH2CH3, R2 = (CH2)3CH3. Antimycin A4: R1= CH(CH3)2
R2 = (CH2)3CH3.
doi:10.1371/journal.pone.0022028.g003
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resulting PCR products were cloned into pGEMT-EZ (Promega)
and sequenced to verify their identity. The upstream arm was
released from pGEMT-EZ with HindIII and BamHI and cloned
into pKC1132 (which contained the RK2 conjugal origin of
transfer and as well as an apramycin resistance gene [22,23] cut
with the same enzymes to result in pKC1132-Up. Next, the
downstream arm was released from pGEMT-EZ with BamHI and
EcoRI and cloned into pKC1132-Up cut with the same enzymes
to result in pKC1132-UpDn. Finally, a hygromycin B resistance
cassette was PCR-amplified from pIJ10700 [24] using oligonucle-
otides RFS94 and RFS95 engineered to contain BamHI sites at
their 59 end. The hygromycin resistance cassette was cloned into
pGEMT-EZ and subsequently released by BamHI digestion and
cloned into pKC1132-UpDn cut with the same enzyme to result in
pKC1132-UpHygDn.
The plasmid pKC1132-UpHygDn was electroporated into E.
coli strain ET12567/pUZ8002 [25] and transferred to Streptomyces
S4 by cross-genera conjugation as previously described [22].
Transconjugants were selected for apramycin resistance. An
apramycin-resistant transconjugant was obtained and subsequent-
ly replica plated to obtain hygromycin-resistant and apramycin-
sensitive colonies, a phenotype indicating that the fscC gene had
been entirely replaced by the hygromycin resistance cassette and
that the plasmid backbone was no longer present. Loss of the
pKC1132-UpHygDn plasmid backbone and mutagenesis of the
fscC gene in the DfscC strain was confirmed by PCR.
In order to disrupt the antC gene a ,1.5 kb internal fragment of
the antC gene was PCR amplified using oligonucleotide primers
RFS121 and RFS122 which were engineered to contain BamHI
and EcoRI restriction sites at their 59 end, respectfully (Table S1).
The resulting PCR product was sequenced to verify its identity
and cloned into pGEMT-EZ to result in pGEMT-Ant. The
apramycin resistance cassette containing a conjugal origin of
transfer (aac(3)IV+oriT) was isolated from pIJ773 as a BamHI
fragment and cloned into the BamHI site (provided by RFS121) in
pGEMT-Ant to result in pGEMT-AntApr. The pGEMT-AntApr
plasmid was electroporated into ET12567/pUZ8002 and mobi-
lized to S4 wild-type and S4 DfscC by conjugation. Transconju-
Figure 4. Gene schematic of the Streptomyces S4 antimycin biosynthetic gene cluster and comparison to putative antimycin clusters
in Streptomyces albus and Streptomyces ambofaciens. The percent amino acid homology shared between S4 proteins and proteins in S. albus and
S. ambofaciens is indicated in the shaded boxes. The draft genomic sequence of S. albus is incomplete and the sequence for the putative antimycin
biosynthetic gene cluster is split over contig 11 and contig 12 with an estimated gap of ,820 bp in the antC gene. The Streptomyces S4 antimycin
biosynthetic gene cluster is located on scaffold06 at coordinates 81953–106578. The partial genome sequences of Streptomyces S4, S. albus J1074,
and S. ambofaciens ATCC 23877 are available under accession numbers CADY00000000, ABYC00000000 and AM238663, respectively. The gene names
for S. albus have been shortened to eliminate the first nine numbers of the gene name (e.g. SalbJ_290= SalbJ_010100000290).
doi:10.1371/journal.pone.0022028.g004
Table 2. Proposed functions of proteins encoded by the
antimycin biosynthetic gene cluster.
Streptomyces S4 protein Proposed function
AntA Sigma factor
AntB Condensation domain
AntC Non-ribosomal peptide synthetase
AntD Polyketide synthase
AntE Dehydrogenase
AntF Acyl-CoA ligase
AntG Thiolation domain
AntH Phenylacetate dioxygenase
AntI Phenylacetate dioxygenase
AntJ Phenylacetate dioxygenase
AntK Phenylacetate dioxygenase
AntL Oxidoreductase
AntM Dehydrogenase
AntN Tryptophan 2,3-dioxygenase
AntO Lipase
doi:10.1371/journal.pone.0022028.t002
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gants were selected for apramycin resistance, a phenotype
indicating that the disruption plasmid has crossed into the
chromosome. Disruption of the antC gene was confirmed by
PCR amplification using oligonucleotide primers (RFS147 and
M13F, and RFS148 and M13R) targeting the DNA sequence
upstream and downstream of the expected site of integration.
LC-MS analysis
Streptomyces S4 wild-type and mutant strains were cultivated in
mannitol-soya flour liquid medium in a 250 ml flask shaking at
270 rpm. For analysis of candidicin production, cultures were
harvested after 10 days of growth, bacterial cells were removed by
centrifugation and the supernatant of three biological replicates
was combined. Fifty milliliters of the combined supernatant was
extracted three times with an equal volume of butanol. Butanol
extracts were combined and evaporated to dryness under vacuum
and the residue was resuspended in 0.5 ml of 50% aqueous
methanol. For analysis of antimycin production, cultures were
harvested after 4 days of growth, bacterial cells were removed by
centrifugation and the supernatant of two biological replicates was
combined and extracted with XAD16 resin (Sigma). Following
extraction, the resin was washed twice with ten milliliters of
deionized water and Streptomyces S4 metabolites were eluted from
the resin with one milliliter of 100% methanol. Prior to LC-MS
analysis the methanol elution was diluted with water to a final
methanol content of 50%. Antimycin A1–A4 standards were
purchased from Sigma Aldrich. Immediately prior to LC-MS
analysis samples were spun in a microcentrifuge at maximum
speed for 5 minutes to remove insoluble material. Only the
supernatant (10 ml) was used for injection into a Shimadzu single
quadrupole LC-MS-2010A mass spectrometer equipped with
Prominence HPLC system as described previously [9]. For co-
injection of antimycin A1-A4 with S4 wild-type extract 5 ml of
standard and 5 ml of wild-type extract were mixed immediately
prior to injection into the LC-MS.
Supporting Information
Figure S1 UV absorbance spectra for antimycin A1–A4
and eight antimycin compounds produced by Strepto-
myces S4. The UV absorbance spectra is shown for A) antimycin
A4 (RT=8.40), B) antimycin A3 (RT=8.97), C) antimycin A2
(RT=9.50), D) antimycin A1 (RT=10.00), E) S4 metabolite 1
(RT=6.38), F) S4 metabolite 2 (RT=6.87), G) S4 metabolite 3
(RT=7.43), H) S4 metabolite 4 (RT=8.00), I) S4 antimycin A4
(RT=8.40), J) S4 antimycin A3 (RT=8.97), K) S4 antimycin A2
(RT=9.50), L) S4 antimycin A1 (RT=10.00).
(PDF)
Figure S2 Mass spectra for antimycin A1–A4 and eight
antimycin compounds produced by Streptomyces S4.
The ESI positive mode detection mass spectra is shown for A)
antimycin A4 (RT=8.40), B) antimycin A3 (RT=8.97), C)
antimycin A2 (RT=9.50), D) antimycin A1 (RT=10.00), E) S4
metabolite 1 (RT=6.38), F) S4 metabolite 2 (RT=6.87), G) S4
metabolite 3 (RT=7.43), H) S4 metabolite 4 (RT=8.00), I) S4
antimycin A4 (RT=8.40), J) S4 antimycin A3 (RT=8.97), K) S4
antimycin A2 (RT=9.50), L) S4 antimycin A1 (RT=10.00).
(PDF)
Table 3. Strains and plasmids used in this study.
Strain or plasmid Genotype or comments Source or reference
Streptomyces S4 Wild type [9]
Streptomyces S4 DfscC S4 fscC null mutant This study
Streptomyces S4 DantC S4 antC disruption mutant This study
Streptomyces S4 DfscC DantC S4 fscC and antC double knockout strain This study
Candida albicans Candidia albicans CA-6 [26]
Escovopsis weberi Escovopsis weberi (CBS 11060) [9]
E. coli ET12567 Non-methylating host for transfer of DNA into Streptomyces spp. (dam, dcm, hsdM) [25]
E. coli TOP10 Host for routine cloning procedures Invitrogen
Plasmids
pGEMT-EZ Cloning vector for PCR products; AmpR Promega
pIJ773 Source of the aac(3)IV+oriT apramycin resistance resistance marker [27]
pIJ10700 PCR template for hygR cassette [24]
pUZ8002 Encodes conjugation machinery for mobilization of plasmids from E. coli to
Streptomyces; KanR
[25]
pKC1132 Suicide vector used for constructing gene deletions in Streptomyces spp. AprR
and contains conjugal origin of transfer
[23]
pKC1132-Up Derivative of pKC1132 containing the fscC upstream knockout arm cloned
into the HindIII and BamHI restriction sites
This study
pKC1132-UpDn Derivative of pKC1132-Up containing the fscC downstream knockout arm
cloned into the BamHI and EcoRI restriction sites
This study
pKC1132-UpHygDn Derivative of pKC1132-UpDn containing the hygromycin resistance cassette
from pIJ10700 cloned into the BamHI site
This study
pGEMT-Ant Derivative of pGEMT-EZ containing the a 1.5 kb fragment of the antC gene, AmpR This study
pGEMT-AntApr Derivative of pGEMT-Ant containing the aac(3)IV+oriT apramycin resistance gene
from pIJ773 cloned into the BamHI site provided by RFS121
This study
AmpR, ampicillin resistance, AprR, apramycin resistance, HygR, hygromycin resistance, KanR, kanamycin resistance, oriT, origin of transfer.
doi:10.1371/journal.pone.0022028.t003
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Table S1 Oligonucleotide primers used in this study.
(DOC)
Acknowledgments
We thank Sabine Gru¨schow and Mark Philo for assistance with LC-MS
and useful discussions, Mark Buttner and Maureen Bibb for providing
pKC1132 and The Genome Analysis Centre for sequencing and assembly
of the Streptomyces S4 genome.
Author Contributions
Conceived and designed the experiments: RFS JB MIH. Performed the
experiments: RFS JB LH. Analyzed the data: RFS JB LH. Contributed
reagents/materials/analysis tools: CB DWY RJMG MIH. Wrote the
paper: RFS RJMG MIH.
References
1. Schultz TR, Brady SG (2008) Major evolutionary transitions in ant agriculture.
Proc Natl Acad U S A 105: 5435–5440.
2. Oh DC, Poulsen M, Currie CR, Clardy J (2009) Dentigerumycin: a bacterial
mediator of an ant-fungus symbiosis. Nat Chem Biol 5: 391–393.
3. Sen R, Ishak HD, Estrada E, Dowd SE, Hong E, et al. (2009) Generalized
antifungal activity and 454-screening of Pseudonocardia and Amycolatopsis bacteria
in nests of fungus-growing ants. Proc Natl Acad U S A 106: 17805–17810.
4. Haeder S, Wirth R, Herz H, Spiteller D (2009) Candicidin-producing
Streptomyces support leaf-cutting ants to protect their fungus garden against the
pathogenic fungus Escovopsis. Proc Natl Acad U S A 106: 4742–4746.
5. Currie CR (2001) A community of ants, fungi, and bacteria: a multilateral
approach to studying symbiosis. Annu Rev Microbiol 55: 357–380.
6. Reynolds HT, Currie CR (2004) Pathogenicity of Escovopsis weberi: the parasite of
the attine ant-microbe symbiosis direclty consumes the ant-cultivated fungus.
Mycologia 96: 955–959.
7. Rodrigues A, Bacci M, Mueller UG, Ortiz A, Pagnocca FC (2008) Microfungal
‘weeds’ in the leafcutter ant symbiosis. Microb Ecol 56: 604–614.
8. Kost C, Lakatos T, Bottcher I, Arendholz W-R, Redenbach M, et al. (2007)
Non-specific association between filamentous bacteria and fungus-growing ants.
Naturwissenschaften 94: 821–828.
9. Barke J, Seipke RF, Gru¨schow S, Heavens D, Drou N, et al. (2010) A mixed
community of actinomycetes produce multiple antibiotics for the fungus farming
ant Acromyrmex octospinosus. BMC Biol 8: 109.
10. Barke J, Seipke RF, Yu DW, Hutchings MI (2011) A mutualistic microbiome:
how do fungus-growing ants select their antibiotic-producing bacteria. Commun
Integr Biol 4: 41–43.
11. Mueller UG, Dash D, Rabeling C, Rodrigues A (2008) Coevolution between
attine ants and actinomycete bacteria: a reevaluation. Evolution 62: 2894–2912.
12. Challis GL, Hopwood DA (2003) Synergy and contingency as driving forces for
the evolution of multiple secondary metabolite production by Streptomyces species.
Proc Natl Acad U S A 100: 14555–14561.
13. Seipke RF, Crossman L, Drou D, Heavens D, Bibb MJ, et al. (2011) Draft
genome sequence of Streptomyces S4, a symbiont of the leafcutter ant Acromyrmex
octospinosus. J Bacteriol;doi:10.1128/JB.05275-11.
14. Chen S, Huang X, Zhou X, Bai L, He J, et al. (2003) Organizational and
mutational analysis of a complete FR-008/candicidin gene cluster encoding a
structurally related polyene complex. Chem Biol 10: 1065–1076.
15. Wendt-Pienkowski E, Huang Y, Zhang J, Li B, Jiang H, et al. (2005) Cloning,
sequencing, analysis, and heterologous expression of the fredericamycin
biosynthetic gene cluster from Streptomyces griseus. J Am Chem Soc 127:
16442–16452.
16. Pandey RC, Toussaint MW, Stroshane RM, Kalita CC, Aszalos AA, et al.
(1981) Fredericamycin A, a new antitumor antibiotic I. production, isolation and
physicochemical properties. J Antibiot 34: 1389–1401.
17. Schoenian I, Spiteller M, Ghaste M, Wirth R, Herz H, et al. (2011) Chemical
basis of the synergism and antagonism in microbial communities in the nests of
leaf-cutting ants. Proc Natl Acad U S A 108: 1955–1960.
18. Dunshee BR, Leben C, Keitt GW, Strong FM (1949) The isolation and
properties of antimycin A. J Am Chem Soc 71: 2436–2437.
19. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ (1990) Basic local
alignment search tool. J Mol Biol 215: 403–410.
20. Miao V, Coeffet-LeGal M-F, Brian P, Brost R, Penn J, et al. (2005) Daptomycin
biosynthesis in Streptomyces roseosporus: cloning and analysis of the gene cluster and
revision of peptide stereochemistry. Microbiol 151: 1507–1523.
21. Currie CR, Wong B, Stuart AE, Schultz TR, Rehner A, et al. (2003) Ancient
tripartite coevolution in the attine ant-microbe symbiosis. Science 299: 386–388.
22. Kieser T, Bibb MJ, Buttner MJ, Chater KF, Hopwood DA (2000) Practical
Streptomyces Genetics. Norwich, UK: The John Innes Foundation. 613 p.
23. Bierman M, Logan R, O’Brien K, Seno ET, Rao RN, et al. (1992) Plasmid
cloning vectors for the conjugal transfer of DNA from Escherichia coli to
Streptomyces spp. Gene 116: 43–49.
24. Gust B, Chandra G, Jakimowicz D, Yuqing T, Bruton CJ, et al. (2004) Lambda
Red-mediated genetic manipulation of antibiotic-producing Streptomyces. Adv
Appl Microbiol 54: 107–128.
25. MacNeil DJ, Gewain KM, Ruby CL, Dezeny G, Gibbons PH, et al. (1992)
Analysis of Streptomyces avermitilis genes required for avermectin biosynthesis
utilizing a novel integrative vector. Gene 111: 61–68.
26. Maconi P, Bistoni F, Boncio A, Boncio L, Bersiani A, et al. (1976) Utilizzazione
di una soluzione salina ipertonica di cloruro di potassio (3M KCl) per
l’estrazione di antigeni solubili da Candida albicalns. Ann Sclavo 18: 61–66.
27. Gust B, Challis GL, Fowler K, Kieser T, Chater KF (2003) PCR-targeted
Streptomyces gene replacement identifies a protein domain needed for biosynthesis
of the sesquiterpene soil odor geosmin. Proc Natl Acad U S A 100: 1541–1546.
Multiple Antifungals Support Leafcutter Ants
PLoS ONE | www.plosone.org 8 July 2011 | Volume 6 | Issue 8 | e22028
